Published 09/18/2024 1:56:00 p.m.

Millions are Taking a Drug that Falls Short of its Promise to Lower Risk of Heart Attack

Summary by MedCity News

While fibrates are proven to lower triglyceride levels, which can serve as a biomarker for cardiovascular disease risk, several major clinical studies from the past 20 years have failed to show a benefit of fenofibrates over and above statins in further reducing heart-related events. The post Millions are Taking a Drug that Falls Short of its Promise to Lower Risk of Heart Attack appeared first on MedCity News.

0 Articles

All

Left

Center

Right

MedCity News

Millions are Taking a Drug that Falls Short of its Promise to Lower Risk of Heart Attack

09/18/2024 1:56:00 p.m.

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated09/18/2024 6:30:58 p.m.Bias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Millions are Taking a Drug that Falls Short of its Promise to Lower Risk of Heart Attack

0 Articles

0 Articles

Millions are Taking a Drug that Falls Short of its Promise to Lower Risk of Heart Attack

Millions are Taking a Drug that Falls Short of its Promise to Lower Risk of Heart Attack

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics